AKSU, S. Et Al. 2012. The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1 , 8-14.

AKSU, S., ŞAHİN, F., Uz, B., YAVUZ, S., Atay, H., Kelkitli, E., ... Turgut, M.(2012). The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, 8-14.

AKSU, SALİH Et Al. "The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, 8-14, 2012

AKSU, SALİH Et Al. "The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, pp.8-14, 2012

AKSU, S. Et Al. (2012) . "The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, pp.8-14.

@article{article, author={SALİH AKSU Et Al. }, title={The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2012, pages={8-14} }